Floatz logo

19 assets in Peritoneal Mesothelioma

Therapeutic assets addressing Peritoneal Mesothelioma, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Cis-Diamminedichloroplatinum Ii
Peritoneal Mesothelioma
National Cancer Institute (NCI)P2BB (64)
Muamycin
Peritoneal Mesothelioma
National Cancer Institute (NCI)P2B (63)
Sodium Thiosulfate
Peritoneal Mesothelioma
National Cancer Institute (NCI)P2B (61)
Fluorouracilum
Peritoneal Mesothelioma
Hospices Civils de LyonP2B (60)
Nivolumab
Peritoneal Mesothelioma
TCR2 TherapeuticsP2B (60)
Ipilimumab
Peritoneal Mesothelioma
TCR2 TherapeuticsP2B (59)
Oxaliplatin
Peritoneal Mesothelioma
Hospices Civils de LyonP2B (56)
Cyclophosphamide
Peritoneal Mesothelioma
TCR2 TherapeuticsP1/2CCC (54)
Domvanalimab
Peritoneal Mesothelioma
Hospices Civils de LyonP2CCC (53)
Immunoglobulin Half-Ig G1-Kappa/Scfv-H-Ch2-Ch3, Anti-(Homo Sapiens Ctla4 (Cytotoxic T-Lymphocyte-Associated Protein 4, Cd152)) And Anti-(Homo Sapienspdcd1 (Programmed Cell Death 1, Pd-1, Pd1, Cd279)), Monoclonal Antibody, Bispecific
Peritoneal Mesothelioma
M.D. Anderson Cancer CenterP2CCC (53)
Zimberelimab
Peritoneal Mesothelioma
Hospices Civils de LyonP2CCC (53)
Amxt1501
Peritoneal Mesothelioma
Aminex Therapeutics, Inc.P1/2CCC (48)
Eflornithine
Peritoneal Mesothelioma
Aminex Therapeutics, Inc.P1/2CCC (48)
Fludarabine
Peritoneal Mesothelioma
TCR2 TherapeuticsP1/2CCC (48)
Gavo-Cel
Peritoneal Mesothelioma
TCR2 TherapeuticsP1/2CCC (48)
tc-510
Peritoneal Mesothelioma
TCR2 TherapeuticsP1/2CCC (48)
Adriamycin
Peritoneal Mesothelioma
National Cancer Institute (NCI)P1CC (43)
ide892
Peritoneal Mesothelioma
IDEAYA BiosciencesP1CC (43)
MAT2A-IN-9
Peritoneal Mesothelioma
IDEAYA BiosciencesP1CC (43)